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Dystroglycan (DG), composed of a and b subunits, belongs to the dys-
trophin-associated glycoprotein complex. a-DG is an extracellular matrix
protein that undergoes a complex post-translational glycosylation process.
The bifunctional glycosyltransferase like-acetylglucosaminyltransferase
(LARGE) plays a crucial role in the maturation of a-DG, enabling its
binding to laminin. We have already structurally analyzed the N-terminal
region of murine a-DG (a-DG-Nt) and of a pathological single point
mutant that may affect recognition of LARGE, although the structural
features of the potential interaction between LARGE and DG remain
elusive. We now report on the crystal structure of the wild-type human
a-DG-Nt that has allowed us to assess the reliability of our murine crystal-
lographic structure as a a-DG-Nt general model. Moreover, we address for
the first time both structures in solution. Interestingly, small-angle X-ray
scattering (SAXS) reveals the existence of two main protein conformations
ensembles. The predominant species is reminiscent of the crystal structure,
while the less populated one assumes a more extended fold. A comparative
analysis of the human and murine a-DG-Nt solution structures reveals that
the two proteins share a common interdomain flexibility and population
distribution of the two conformers. This is confirmed by the very similar
stability displayed by the two orthologs as assessed by biochemical and
biophysical experiments. These results highlight the need to take into
account the molecular plasticity of a-DG-Nt in solution, as it can play an
important role in the functional interactions with other binding partners.
Dystroglycan (DG) is a heterodimeric transmembrane
glycoprotein that is a part of the multimeric dystrophin–
glycoprotein complex and plays a crucial role in the
association of cells with the basement membranes [1].
DG links the basal lamina with the cytoskeleton by
bridging the intracellular dystrophin to a plethora of
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DG, dystroglycan; Dmax, maximum size of the particle; DSF, differential scanning fluorimetry; ECM, extracellular matrix; EOM, ensemble
optimization method; ha-DG-Nt, human a-DG-Nt; Ig-like, immunoglobulin-like; LARGE, like-acetylglucosaminyltransferase; MMexp,
experimental molecular mass of the solute; ma-DG-Nt, murine a-DG-Nt; NSD, normalized spatial discrepancy; Rg, radius of gyration; rmsd,
root mean square deviation; S6 domain, small subunit ribosomal protein S6 of Thermus thermophilus; SAXS, small-angle X-ray scattering;
Tm, melting temperatures; Vp, excluded volume of the hydrated particle; a-DG-Nt, N-terminal region of a-DG; a-DG, a-dystroglycan; b-DG,
b-dystroglycan.
1064 FEBS Open Bio 7 (2017) 1064–1077 ª 2017 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
extracellular matrix (ECM) proteins, that is, laminin,
agrin, and perlecan, thus offering stability to tissues.
DG is highly expressed in skeletal muscle where it was
first discovered [2] and where it confers structural stabil-
ity to the sarcolemma during contraction, but it is also
strongly expressed in heart, in brain, and in peripheral
nerves, where it is involved in various physiological pro-
cesses [3]. Moreover, DG has been also associated with
Old Word arenaviral infections, acting as a receptor for
virus anchoring [4].
Dystroglycan is encoded by a single gene (DAG1) [2]
and the corresponding precursor is proteolytically
cleaved within the endoplasmic reticulum, resulting in
the formation of the extracellular a-dystroglycan (a-
DG) and the transmembrane b-dystroglycan (b-DG).
In their mature forms, a- and b-DG are linked together
through noncovalent interactions involving the N-term-
inal and the C-terminal regions of b-DG and a-DG,
respectively. a-DG undergoes a complex, and is still not
fully understood, glycosylation post-translational pro-
cess, which involves several enzymes at various stages
of a-DG maturation [5] in both endoplasmic reticulum
and Golgi apparatus. A correct a-DG glycosylation has
been shown to be critical for its physiological functions.
In a family of neuromuscular diseases called secondary
dystroglycanopathies, the hypoglycosylated forms of a-
DG, resulting from defective enzymes responsible for a-
DG glycosylation, display limited binding capabilities
toward laminin with severe implications for health [6].
A low degree of a-DG glycosylation has also been
found in rare diseases caused by single point mutations
hitting the DG gene [7–9]. In recent years, it has been
discovered that the Ca2+-dependent interaction of a-
DG with its main binding partner in ECM, the LG
domain, is specifically mediated by a novel polysaccha-
ride [10]. The a-DG glycosylation biosynthetic path-
ways involve a kinase and several glycosyltransferases
[5], among which the bifunctional glycosyltransferase
like-acetylglucosaminyltransferase (LARGE) that adds
the repeating disaccharide unit (-a3-GlcA-b3-Xyl-) to a
glycan anchored at the site defined by Thr317 and
Thr319 [11]. Indeed, it has been reported that the elon-
gation of the glycan operated by LARGE requires the
presence of the N-terminal region of a-DG (a-DG-Nt),
which is thought to act as a recognition site for
LARGE before being processed by a furin-like
proprotein convertase [12,13]. It has been proposed that
a-DG-Nt would be able to bind other partners in the
ECM [14], but the biological implications of these
potential interactions remain elusive [15].
We aimed at characterizing the biophysical and bio-
chemical bases behind the biological function of a-DG,
and our efforts have been focused on the comprehension
of the molecular determinants that modulate its binding
abilities [16]. An electron microscopy study showed that
a-DG assumes a dumbbell-like shape, with two globular
N-terminal and C-terminal regions at the extremes of a
mucin-like region [17]. Furthermore, the crystal struc-
ture of the murine N-terminal region disclosed a modu-
lar architecture composed by an immunoglobulin-like
(Ig-like) domain and a second domain similar to the
small subunit ribosomal protein S6 of Thermus ther-
mophilus (S6 domain) [18]. Although the experimental
structure of the C-terminal region of a-DG is still
unknown, homology modeling suggests that its fold is
likely to be a second Ig-like structure [19]. According to
the crystallographic structure, murine a-DG-Nt (ma-
DG-Nt) assumes an overall rather compact fold, with
the Ig-like and S6 domains interacting with each other
and linked together by a flexible loop [18]. Such an orga-
nization has been observed in the crystal structure of the
murine a-DG missense pathological mutant T190M,
which displays the same fold, mutual orientation, and
interaction between the Ig-like and S6 domains observed
for WT a-DG-Nt [20]. Despite such high degree of struc-
tural similarity, it has been proposed that T190M might
have a reduced ability to assist LARGE in its glycan
elongation action, and the resulting a-DG hypoglycosy-
lation leads to a form of limb-girdle muscular dystrophy
[7]. The comparison of the WT and T190M crystallo-
graphic models ruled out any effect of the T190M muta-
tion on the Ig-like and S6 domains folding, as earlier
proposed by a computational study [21]. Therefore, we
considered whether the murine crystallographic structure
could be reliably used as a general structural model for a-
DG-Nt. In addition, we have explored a-DG-Nt propen-
sity for plasticity in solution by small-angle X-ray scat-
tering (SAXS) analysis of both murine and human
proteins. The high-resolution crystal structure of human
a-DG-Nt (ha-DG-Nt) has also been determined, in order
to assess the structural similarities between the two
orthologs, which are 93% identical in their amino acid
sequence. The combination of the high- and low-resolu-
tion structural data (respectively, in the crystals and in
solution) with biochemical and biophysical experiments
proves that the murine and human proteins share a
highly conserved overall architecture as well as a striking
parallel structural flexibility in solution.
Results
Conformational stability of the N-terminal
domains of murine and human a-dystroglycan
Conformational stabilities of murine and human
a-DG-Nt were compared by biochemical and
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biophysical experiments, that is, differential scanning
fluorimetry (DSF) and limited proteolysis assays.
In the DSF assay, thermally induced protein denatu-
ration is monitored by the increase in SYPRO Orange
fluorescence upon exposure of hydrophobic patches
during protein unfolding. The comparison of the
resulting thermal unfolding profiles and melting tem-
peratures (Tm) can be used to infer differences in the
conformation and therefore in the thermal stability of
the proteins [22].
Figure 1 shows the changes in fluorescence emission
of the murine and human proteins upon thermal
unfolding in the presence of the dye.
Both the murine and human variants showed very
low background fluorescence in the pretransition
region that is quite flat. Their denaturation curves are
almost superimposable and suggest a two-transition
unfolding process typical of protein containing two
independently folded domains. The Tm values for the
first transition obtained from the Boltzmann sigmoid
fitting of the data (43.76  0.08 °C and 43.94 
0.11 °C for murine and human variants, respectively)
did not show any significant difference, supporting the
hypothesis that the two proteins share a very similar
conformational stability in solution. A similar thermal
stability of the two proteins is also clear from the
inspection of the second transition, although in this
case the Tm could not be calculated because it was not
possible to reach the aggregation region even increas-
ing the final temperature to the upper range value of
the instrument.
Limited proteolysis was also used to probe conforma-
tional stability, assuming that proteolytic recognition
sites become accessible upon unfolding. Indeed, this
technique is widely used to examine flexible and exposed
regions, considering that proteolysis occurs exclusively
at ‘hinges and fringes’ [23] and conformational parame-
ters such as accessibility and segmental mobility corre-
late quite well with exposed proteolytic sites [24].
Limited proteolysis experiments (data not shown) with
a panel of seven different proteases did not reveal any
significant difference in conformation stability or flexi-
bility between ma-DG-Nt and ha-DG-Nt.
Crystallographic structure of human
a-dystroglycan N-terminal domain
The crystallographic structure of ha-DG-Nt has been
determined at a resolution of 1.8 A. Upon completion
of the crystallographic refinement, the final R-factor was
0.163 (R-free = 0.195), with residues 52–60, 163–179,
and 305–315 missing in the final model as no reliable
electron density could be detected for these regions. A
lower-quality electron density was also observed for
the flexible regions encompassing residues 89–91 and
181–185. The region comprising residues 159–162
shows signs of multiple conformations, but any
attempt to model it during the refinement did not
improve the 2Fo–Fc and Fo–Fc density maps, nor the
refinement quality indicators.
The Ig-like domain (residues 62–160) and the S6
domain (residues 182–305) assume the same relative
orientation as observed in ma-DG-Nt [18] (Fig. S1A,
B) with a root mean square deviation (rmsd) between
the murine and ha-DG-Nt crystallographic models
equal to 0.468 A (calculated on 225 common Cas).
Differences between the primary structures of
human and murine a-DG (see Table 1 for alignment)
were easily identified in ha-DG-Nt, according to the
2Fo-Fc and Fo-Fc density maps (see Fig. S2 for
selected examples).
The differences in the primary structures are all
mapped on the protein surface of ha-DG-Nt (Fig. 2
and Fig. S3), with residues fully or partially exposed
to the bulk solvent.
The residues that are different in ha-DG-Nt and ma-
DG-Nt are clustered in four small patches (Table 2)
that are longitudinally distributed along one edge of the
proteins (Fig. 2). Such an uneven distribution in a-DG-
Nt seems to be an intrinsic property of this protein
region (Fig. S4). Patches P1 and P2 are located on the
Ig-like domain, whereas patches P3 and P4 are on the
S6 domain (Fig. S3). Patches P2 and P3 face each other
in a large cleft lined by the b-strands B, D, and E of the
Fig. 1. Thermal denaturation assay by DSF. Comparison of
the thermal unfolding curves for murine and human a-DG-Nt.
The increase in fluorescence emission at 516 nm indicates the
association of SYPRO Orange with exposed hydrophobic residues
as the protein unfolds. Experiments were performed in triplicate: A
single representative curve is shown for clarity.
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Ig-like domain and by the a-helices H2 and H3 of the
S6 domains (see [18] and Fig. S3B). P2 and P3 patches
do not show any explicit mutual interaction.
While the global rmsd is quite low, small but signifi-
cant deviations between superposed Cas (around 0.7–
1.2 A against average values of ~ 0.1–0.3 A and a
maximum-likelihood error estimate of 0.233 A) are
observed in the zones encompassing residues 111–114,
134–145, and 155–162. The zone defined by residues
134–145, which includes N- and C-terminal regions of
b-strands F and G and the turn connecting them [18],
does not show any remarkable structural variation and
the Cas deviations above the average are probably due
to the intrinsic dynamics of the turn connecting the
two strands. Apart from the flexible linker (residues
161–181) connecting the Ig-like and the S6 domains,
the zone encompassing residues 111–114 shows the
highest deviations between superposed Cas (Fig. S2A),
which is probably due to the very different nature of
the residues occupying the same topological position in
the two proteins (Pro110 in ma-DG-Nt and Ser112 in
ha-DG-Nt). It is well known that prolines reduce the
conformational freedom of the proteins backbone [25],
and it is likely that its substitution in the corresponding
position of ha-DG-Nt with Ser112 may affect the local
main chain conformation. Indeed, in ha-DG-Nt, resi-
dues 112–114 assume a helix-310 conformation, instead
of the turn observed in ma-DG-Nt. We do not observe
any relevant backbone deviation between ma-DG-Nt
and ha-DG-Nt for the residues being part of patches
P3 and P4. Nonetheless, the interacting network of
residues spatially closer to His212 and Arg215 (patch
P3) is different from that observed in the corresponding
region of ma-DG-Nt (Fig. 3A–B). This discrepancy is
likely due to the different chemical nature of the posi-
tively charged His and Arg amino acids (ha-DG-Nt)
with respect to the polar Asn and Gln residues (ma-
DG-Nt). This notion is further supported by the com-
parison of the electrostatic potentials of ma-DG-Nt
and ha-DG-Nt, which are locally different around resi-
dues 212 and 215 (Fig. 3A–B), while overall being quite
similar (Fig. S1A-B).
The ha-DG-Nt and ma-DG-Nt crystal structures
display the most significant structural differences in
Table 1. Sequence alignment.
βA’     βB              βC βD
Homo sapiens TT      TT     TTTT      TTT   TTT
Mus musculus                                  TT      TT     TTT       TTT   TTT      
Homo sapiens 52 SVLSDLHEAVPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWD 111
Mus musculus 50 SVLSDFQEAVPTVVGIPDGTAVVGRSFRVSIPTDLIASSGEIIKVSAAGKEALPSWLHWD 109
*****::**********************:**********:*******************
βE            βF              βG
Homo sapiens                                       TTTT 
Mus musculus            TTTT                       TTTT               TTT           
Homo sapiens 112 SQSHTLEGLPLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTAS 171
Mus musculus 110 PHSHILEGLPLDTDKGVHYISVSAARLGANGSHVPQTSSVFSIEVYPEDHNEPQSVRAAS 169
.:** *******************:********:****************.* ****:**
β1                                 β2
Homo sapiens TTTT         TT                                TT
Mus musculus                       TTTT         TT                                TT
Homo sapiens 172 PDPGEVVSSACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVV 231
Mus musculus 170 SDPGEVVPSACAADEPVTVLTVILDADLTKMTPKQRIDLLNRMQSFSEVELHNMKLVPVV 229
.******.********************************:**:****************
β3              β4
Homo sapiens            TTT  TTTTT      TTTT             TTTTTTT  
Mus musculus            TTT  TTTTT      TTTT             TTTTTTT  
Homo sapiens 232 NNRLFDMSAFMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLG 291
Mus musculus 230 NNRLFDMSAFMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIRGVETPAREGAMSAQLG 289
*******************************************:***:************
β5       
Homo sapiens             
Mus musculus                                  
Homo sapiens 292 YPVVGWHIANKKPPLPKRVRRQIH 315
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the flexible linker (see Fig. S2A,B) connecting the Ig-
like and S6 domains. According to the ha-DG-Nt
refined model, the conformation of the N-terminal
part of the linker, the only one reliably modeled in
both structures, differs from that observed in ma-DG-
Nt crystal structure. This finding is not surprising,
being the linker very flexible [20], probably playing a
pivotal role in a-DG structural plasticity as discussed
in the next paragraphs. As mentioned above, the linker
is also one of the a-DG zones with the highest
sequence variability among different species (see [26]
and Table S1). Besides, the presence of Leu164 in
ha-DG-Nt (not modeled in the ha-DG-Nt crystallo-
graphic structure) instead of Pro162 in the correspond-
ing position of ma-DG-Nt may influence ha-DG-Nt
conformational variability with respect to ma-DG-Nt.
Indeed, residues 159–161 assume a helix-310 conforma-
tion in ha-DG-Nt, whereas they display a turn/coil
conformation in ma-DG-Nt.
Association state and overall parameters of the
N-terminal domains of murine and human
a-dystroglycan in solution
Small-angle X-ray scattering experiments were per-
formed to compare the conformations in solution of
ma-DG-Nt and ha-DG-Nt.
Fig. 2. P1–P4 mapping on ha-DG-Nt structure and accessible
surface. The ha-DG-Nt model is depicted as ribbon representation,
with the Ig-like and S6 domains colored in pale yellow and in pale
pink, respectively. Residues belonging to the patches P1-P4 are
depicted as a stick-and-ball model, and their solvent-accessible
surfaces are mapped on the ha-DG-Nt surface. Residues and
surfaces belonging to different patches are colored differently.
A B
Fig. 3. Electrostatic potential maps of ma-DG-Nt and ha-DG-Nt. The electrostatic potential (kbT/ec) is mapped on the human and murine a-
DG-Nt-accessible surfaces. Molecular models are represented as ribbons with selected residues depicted as stick-and-ball. (A) ha-DG-Nt,
208–221 stretch. (B) ma-DG-Nt, 206–219 stretch.
Table 2. Amino acid differences between ma-DG-Nt and ha-DG-Nt.
Patch 1 (P1) Patch 2 (P2) Patch 3 (P3) Patch 4 (P4)
Res ma-DG-Nt ha-DG-Nt Res ma-DG-Nt ha-DG-Nt Res ma-DG-Nt ha-DG-Nt Res ma-DG-Nt ha-DG-Nt
92 Asp Glu 81 Ser Thr 212 Asn His 275 Arg His
136 Ala Thr 112 Pro Ser 215 Gln Arg 279 Thr Ala
145 Val Ile 113 His Gln
116 Ile Thr
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The protein solutions were analyzed at different con-
centrations (Table 3), and in both cases, no systematic
changes with the solute concentration could be
observed, although the murine protein showed a cer-
tain degree of aggregation, likely due to the higher
concentration of the stock solution.
The experimental SAXS curves, obtained at the
highest concentration of ma-DG-Nt and ha-DG-Nt,
are displayed in Fig. 4A,B, respectively, and the com-
puted p(r) distance distribution functions are displayed
in Fig. 5; the overall parameters extracted from the
SAXS data are summarized in Table 3 (additional
details on SAXS structural parameters are reported in
Table S2).
The molecular mass (MM) of the proteins, estimated
from the relative forward scattering intensities (s = 0,
with s the scattering vector), suggests that both pro-
teins are monomeric in solution at all conditions tested
and is in good agreement with the value estimated from
the primary sequences (around 28.5 kDa). This is fur-
ther corroborated by excluded volume of the hydrated
protein molecules (Vp), consistent with the empirical
finding for globular proteins that the hydrated volume
expressed in nm3 should numerically be about twice the
MM in kDa. The experimental radius of gyration (Rg)
and maximum size (Dmax; Table 3) point to an elon-
gated shape of the proteins, and the two p(r) functions
that nicely overlap (Fig. 5) display an asymmetric tail,
typical of elongated particles.
It is interesting to note that in both cases, the
scattering curves computed by the CRYSOL program [27]
Table 3. Overall parameters calculated from SAXS data analysis.
Samples Concentration (mgmL1) Rg (A) Dmax (A) Vp (A3) MMexp (kDa) vcrystal vCORAL vab initio vEOM
ma-DG-Nt 0.22–3.38 25.2  0.04 90  3 44 000  2000 25.1  3.0 2.87 0.84 0.81 0.63
ha-DG-Nt 0.24–4.2 25.1  0.04 90  3 44 000  2000 28.8  3.0 2.25 1.17 1.14 1.06
Notations: MMexp, experimental molecular mass of the solute; vcrystal, vCORAL, vab initio, and vEOM, discrepancy (chi-square value) for the fit
from the crystallographic structures with the missing regions reconstructed by CORAL keeping fixed the two domains, from rigid body mod-
eling using CORAL, from ab initio modeling using DAMMIN, and from EOM, respectively.
Fig. 4. Experimental X-ray scattering data and obtained fits for (A)
ma-DG-Nt and (B) ha-DG-Nt. Experimental SAXS patterns,
scattering calculated from the crystallographic models (‘fit crystal’,
continuous line), scattering calculated from rigid body models
obtained by CORAL (‘fit CORAL’, dashed line). The plots display
the logarithm of the scattering intensity as a function of
momentum transfer. The zoomed regions of these graphs at low
angles are presented in the insert.
Fig. 5. Distance distribution functions for ma-DG-Nt and ha-DG-Nt.
Overlaid of the p(r) distance distribution functions calculated from
the experimental SAXS data of ma-DG-Nt (black dotted line) and
ha-DG-Nt (gray solid line).
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based on the crystallographic models (PDB ID 1U2C
and 5LLK for ma-DG-Nt and ha-DG-Nt, respec-
tively) give a poor fit to the respective experimental
data (data not shown). Even upon reconstruction of
the missing regions (around 10 amino acids at both N-
terminal and C-terminal regions and the missing linker
between the two domains that are kept fixed) using
CORAL [28], the fit is not improved (vcrystal in Table 3
and ‘fit crystal’ in Fig. 4 with the zoomed portions at
low angles in the inserts). It can be thus concluded that
both murine and human a-DG-Nt are monomeric in
solution, even at relatively high concentrations, but
they show a significantly more extended conformation
than in the crystallographic models.
Molecular shape reconstruction of the N-terminal
domains of murine and human a-dystroglycan in
solution
Two different strategies have been employed to recon-
struct the macromolecular shapes of the two proteins
in solution.
At first, low-resolution three-dimensional models of
ma-DG-Nt and ha-DG-Nt were reconstructed from
the experimental X-ray scattering data using the ab ini-
tio modeling program DAMMIN [29] (Fig. 6), with all
models providing an excellent fit to the experimental
data (Table 3, vab initio). The final DAMMIN models
are the result of analyzing and averaging 10 indepen-
dent solutions. The normalized spatial discrepancy
(NSD) value, which describes the similarity between
the different models produced by the program [30], is
low for both the murine and human models
(0.478  0.029 and 0.547  0.014, respectively), indi-
cating that the multiple solutions built by the program
are very similar to each other. The visible similarity in
the shapes of the two models suggests that at low reso-
lution, no differences could be detected.
A second approach to molecular shape reconstruc-
tion consisted in a rigid body modeling of the two pro-
teins from the scattering data conducted by using the
program CORAL [28]. High-resolution models of indi-
vidual Ig-like and S6 domains in the corresponding
crystal structures were combined with different confor-
mations of flexible dummy residue linkers. The relative
orientations of the two domains and the reconstruction
of the flexible missing loops linking the Ig-like and the
S6 domains were optimized. The CORAL models
nicely overlay with the scattering curves (vCORAL in
Table 3 and ‘fit CORAL’ in Fig. 4 with the zoomed
portions at low angles in the inserts) and well super-
pose into the SAXS envelopes of the ab initio models
(Fig. 6). It is interesting to notice that, probably due
to packing stabilizing interactions of the crystal lattice,
the two crystallographic structures are more compact
than the respective conformations in solution, whose
more elongated shapes are most evident in the asym-
metric tail at the higher r of their p(r) distributions
(Fig. 5). As a quantitative measure of structure com-
pactness, the distances between centers of masses of
the Ig-like and S6 domains in the crystallographic
models (29.7 and 29.9 A in the human and murine
models, respectively) have been compared to those of
the CORAL models (33.6 and 34.4 A in the human
and murine models, respectively), confirming the exis-
tence of more extended conformations in solution. The
most straightforward explanation is that the solution
structures of the N-terminal regions of murine and
human a-DG display a conformation that is more flex-
ible than the one inferred from their crystal structures.
Interdomain flexibility of the N-terminal domains
of murine and human a-dystroglycan in solution
More extended ma-DG-Nt and ha-DG-Nt solution
structures are in agreement with the evidence of a
Fig. 6. Structural models of ma-DG-Nt (A) and ha-DG-Nt (B).
Averaged and filtered ab initio beads models as obtained by
DAMMIN (green and cyan semitransparent surfaces)
superimposed on the typical CORAL models (green and cyan
cartoon representations for the folded Ig-like and S6 domains,
spheres for the restored missing fragments).
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disordered region linking the Ig-like and S6 domains,
as suggested by the crystallographic analysis. Indeed,
linker flexibility could allow variability in the relative
orientation of the individual domains, resulting in
structural plasticity.
An analysis of the interdomain flexibility and size
distribution of possible multiple configurations in solu-
tion was conducted by using the ensemble optimiza-
tion method (EOM) [31], obtaining typical optimized
ensembles that fit well the measured scattering data
(Table 3). The EOM analyses of the murine and ha-
DG-Nt are presented in Fig. 7 as a size distribution,
plotting the Rg of the structures forming the random
pool and the selected ensembles against their relative
frequencies.
The Rg distributions of these ensembles (Fig. 7, solid
lines) are very similar to each other and nearly as
broad as the distribution of randomly generated mod-
els (Fig. 7, dashed lines), supporting the hypothesis of
a certain degree of interdomain flexibility. Moreover,
these Rg distributions are both characterized by a
bimodal profile. Indeed, the predominant fractions
(around 60%) represent relatively compact models
with Rg of about 21–25 A, while a very small fraction
(around 15%) of models with Rg of about 30–35 A is
due to more elongated configurations: two molecular
structures representative of different conformations are
shown in Fig. 7 (compact conformations on the left
and extended conformations on the right). This inter-
domain flexibility may confer structural plasticity,
which in turn may represent the molecular basis regu-
lating a-DG maturation and/or modulating the inter-
actions with other physiological binding partners.
Discussion
The aim of this study was to investigate the compre-
hensive structure of a-DG-Nt in solution. By explor-
ing for the first time the conformational landscape of
human and mouse a-DG-Nts in solution by means
of SAXS experiments, we disclosed unexpected
shared features of a-DG-Nt that may help to eluci-
date the molecular basis of the physiological and
pathological functions of a-DG. Besides, the analysis
of the SAXS and crystallographic data of the two
orthologs validates previous results and the structure
of ma-DG-Nt as a fully descriptive model for ha-
DG-Nt. This notion is further supported by the com-
parison of the conformational stability of the two
orthologs as assessed by biochemical and biophysical
experiments.
The ha-DG-Nt crystal structure displays the same
fold of ma-DG-Nt, with few structural differences. It
is interesting to note that when mapping the not con-
served amino acids on the high-resolution 3D struc-
ture, they cluster around four distinct patches, which
span along only one edge of the a-DG-Nt longest axis
(Figs 2 and S4). Such clustering might have a biologi-
cal significance; that is, these patches might represent
‘hotspots’ for transient species-specific protein–ligand
interactions. On the other hand, the conserved surface
involving especially the S6 domain (Fig. S1) may be of
functional relevance for LARGE recognition along the
a-DG maturation pathway. Moreover, it is interesting
to note that the patch involving residues 112 and 113
in ha-DG-Nt just follows Asp111, whose mutation to
Asn has been related to pathological a-DG hypoglyco-
sylation [8], suggesting that this residue is involved in
Fig. 7. Rg distributions for the EOM models of ma-DG-Nt (A) and
ha-DG-Nt (B). The distributions for the initial random pools of
models are shown as green and blue dot lines; green and blue
solid lines correspond to the selected ensembles. The
representative conformations are shown near the distributions:
compact conformation on the left and extended conformation on
the right of the respective distributions. Folded domains are
depicted as cartoons (ma-DG-Nt in green and ha-DG-Nt in blue);
linkers and the N-terminal and C-terminal reconstructed regions are
represented by spheres.
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the complex mechanism leading to the mature, fully
glycosylated a-DG.
In order to explore the molecular structure of the a-
DG-Nt in solution, we have undertaken a SAXS
study. SAXS is the technique of election for low-reso-
lution structural studies in solution, especially valuable
for flexible systems, whose conformational variability
description is precluded to crystallography [32]. While
SAXS cannot infer the molecular structure at the
atomic level like X-ray crystallography can mostly do,
it offers the unique opportunity to obtain, albeit at
lower resolution, a structural model in solution, free of
the packing forces that may instead influence a crystal-
lographic model [33]. Indeed, while packing effects are
not expected to affect the compact folds of the single
domains, they could in this case have an impact on the
relative orientation of the Ig-like and the S6 domains.
Mutual domains orientation may be assisted by the
flexible 20-residue-long linker connecting them, which
may influence the overall conformation of the a-DG-
Nt. Combined with the crystallographic models of
murine and ha-DG-Nt s, SAXS analysis may provide
a reliable low-resolution model of a-DG at near-phy-
siological conditions [34].
The SAXS study presented here points to structural
models significantly different from those observed in
the murine and ha-DG-Nt crystal structures. Accord-
ing to their solution structures obtained by SAXS data
analysis exploiting the respective crystal structures,
ma-DG-Nt and ha-DG-Nt both assume a remarkably
less compact structure in solution than that observed
in the crystal structures. The comparison of ma-DG-
Nt and ha-DG-Nt p(r) distributions pinpoints to a
more extended conformation, a feature that is notably
similar for the two orthologs in solution (Fig. 5). Fur-
thermore, the ma-DG-Nt and ha-DG-Nt SAXS mod-
els nicely fit on the low-resolution molecular envelopes
obtained by DAMMIN ab initio method. Employing
the program CORAL [28], apart from rigid body fit-
ting of the Ig-like and S6 domains, we have been able
to reconstruct the missing parts of both ma-DG-Nt
and ha-DG-Nt. While the N- and C-terminal zones of
the Ig-like and S6 domains, respectively, assume
extended conformations, the linker connecting the two
subdomains displays a more compact structure, rather
similar in the two proteins despite important differ-
ences in their amino acid sequences. It is interesting to
note that by comparing the crystal structures with the
CORAL models, the S6 domain appears to be rotated
by about 90° to each other around the Ig-like domain.
Even if this observation might suggest some functional
implications for this assembly, it must be taken into
account that the CORAL models have some intrinsic
limitations due to the assumption of the models to be
rigid. Indeed to overcome this bias and to gain further
information on the conformational variability in ma-
DG-Nt and ha-DG-Nt in solution, the interdomain
flexibility has been assessed by using the EOM method
[31]. According to our analysis, murine and ha-DG-Nt
share a common behavior in solution, as shown by the
similarity in their bimodal Rg distribution curves, with
comparable maxima and slightly different frequencies.
Indeed, both ma-DG-Nt and ha-DG-Nt in solution
are partitioned among few principal populations,
which differ in their compactness (Fig. 7). More
extended conformations seem to be present, but their
relative abundance is low when compared with the
most frequent. The common conformational character-
istics of murine and ha-DG-Nt suggest that in solution
a-DG may have a more complex behavior than
expected only on the basis of its crystal structures.
According to the present SAXS study, the struc-
tural plasticity of the a-DG-Nt seems to be a general
property of this protein, as ma-DG-Nt and human a-
DG-Nt show common structural features. Such unex-
pected conformational variability of the a-DG-Nt is
of great interest and it may play a functional role in
its ability to interact with different partners, either
inside the cell along its maturation pathway or at the
level of the ECM, or in both. It has been proposed
that a-DG-Nt can assist the bifunctional glycosyl-
transferase LARGE in its complex enzymatic actions,
a function that may require a-DG-Nt to assume dif-
ferent, functionally relevant conformational states. It
is also tempting to speculate that the functional flexi-
bility of the a-DG-Nt was positively selected as it
conferred a strong advantage for the multistep matu-
ration pathway. Along this pathway, concerted con-
nections must be established between a plethora of
glycosyltransferases and regulatory enzymes that
extensively decorate the mucin-like region within the
Golgi lumen [35]. Further biochemical and structural
work is warranted in order to assess the possibility of
direct interactions of a-DG-Nt with some of these
enzymes. Furthermore, the conformational variability
in a-DG highlights the consolidated notion that a-
DG displays a distinct structural modularity, in line
with the recent analysis of a-DG conserved domain
organization in metazoan [36]. The autonomous fold-
ing modular nature of the entire a-DG-Nt [26]
prompted its possible use as a serum biomarker in
DMD patients [37] or also in human uterine fluid to
determine uterine receptivity [38].
In line with these results, molecular plasticity of a-
DG in solution should be considered and investigated
to enhance our understanding of the molecular basis
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of the physiological and pathological role of a central
component of the dystrophin–glycoprotein complex.
Materials and methods
Cloning, expression, and purification
As previously reported for the murine a-DG N-terminal
region, ma-DG-Nt(50–313)R168H [18], we have cloned the
DNA fragment encoding for its human counterpart, ha-DG-
Nt(52–315), into the bacterial vector pHis-Trx, for the
expression of the protein as a thioredoxin fusion product,
with an N-terminal His6 tag and a thrombin cleavage site.
We also introduced within ha-DG-Nt(52–315) the additional
mutation R170H, in order to make the protein more prote-
olytically resistant [22]. The recombinant ha-DG-Nt(52–315)
R170H was obtained as previously reported [20]. Namely, it
was expressed as fusion protein in Escherichia coli BL21
(DE3) Codon Plus RIL, purified by nickel affinity chro-
matography, cleaved by thrombin, and further purified by
anion-exchange and gel filtration chromatography.
Differential scanning fluorimetry (DSF)
Differential scanning fluorimetry experiments were carried
out on a CFX96 Touch Real-time PCR instrument (Bio-
Rad, Hercules, CA, USA). Measurements were taken using
an excitation wavelength of 470–505 nm and an emission
wavelength of 540–700 nm. Data were acquired using a tem-
perature gradient from 20 to 90 °C in 0.2 °Cmin1 incre-
ments. The samples contained 0.5 mgmL1 murine and ha-
DG-Nt proteins in 20 mM Tris, 150 mM NaCl pH 7.5, and
909 SYPRO Orange (Sigma-Aldrich, St. Louis, MO, USA)
in a total volume of 25 lL. The melting curves represent the
fluorescence increase arising from the association of SYPRO
Orange with exposed hydrophobic residues as the protein
unfolds with increasing temperature [33]. Experiments were
performed in triplicate. Fluorescence data were analyzed and
the Tm, represented by the inflection points of the transition
curves, were calculated using the Boltzmann sigmoid fit [22].
Limited proteolysis
ma-DG-Nt and ha-DG-Nt were subjected to limited prote-
olysis at 37 °C at a final concentration of 30 lM in 25 mM
Tris pH 7.5, 150 mM NaCl buffer. A panel of proteases
from Proti-Ace kits (Hampton Research, Aliso Viejo, CA,
USA), that is, bromelain, proteinase K, subtilisin, ther-
molysin, trypsin, endoproteinase Glu-C, and clostripain
(endoproteinase Arg-C), were tested at a final concentration
of 2 lgmL1. The reactions were stopped after 1, 5, 10,
20, 40, and 60 min by adding SDS sample buffer to ali-
quots of the reaction mixtures. The samples were analyzed
by performing 15% SDS/PAGE and Coomassie staining.
Crystallization, data collection, structure
solution, and refinement
Attempts to grow crystals of ha-DG-Nt by using the hang-
ing-drop vapor diffusion method from conditions similar to
those previously reported for both wild-type ma-DG-Nt
and its mutant T190M [18,20] were not successful. While
exploring new crystal growth conditions by using commer-
cial high-throughput screening kits (100 + 100 nL of pro-
tein and precipitant solution at both 277 and 297 K), we
also attempted cross-seeding methods starting from
already-grown crystals of ma-DG-Nt mutant. While the
screenings did not reveal new crystallization conditions,
cross-seeding, based on well-established protocols [39,40],
resulted in the growth of well-shaped crystals. Precipitant
conditions (0.6–1.4 M sodium citrate buffer) and pH (6.8–
7.2) were screened by mixing 1 lL of protein solution
(10 mgmL1 ha-DG-Nt in 150 mM NaCl, 25 mM Tris, pH
7.5) with 1 lL of precipitant solution; the drops were equi-
librated at 277 K for 3–6 days before seeding. Fully grown
crystals were obtained in 2 weeks after seeding in the opti-
mized growth conditions (0.8 M sodium citrate buffer, pH
7.2). Both streak-seeding and microseeding methods were
attempted with seeds stock prepared following the manu-
facturer’s protocol (Hampton Research, HR2-320 User
Guide). The best-shaped crystals were obtained by using
the streak-seeding method. Repeated streak seeding (two to
three times), following the same protocol but at optimal
precipitant and pH conditions, increased crystal dimensions
and improved their diffraction quality.
Data collections were carried out at the XRD1 beamline
at ELETTRA (Trieste, Italy) [41,42] using a Pilatus-2M
(Dectris Ltd., Baden, Switzerland) detector and the wave-
length of 1.00 A. Data collection was carried out at 100 K
after having quickly dipped the crystals into a cryoprotec-
tant solution (25% ethylene glycol added to the precipitant
solution) and frozen in liquid nitrogen. Indexing, integra-
tion, and data reduction of the diffraction data were car-
ried out by the XDS program [43]. Data reduction statistics
of the ha-DG-Nt dataset are reported in Table 4.
The structure solution of ha-DG-Nt was obtained by
Patterson search methods, using the PHASER software,
implemented in the PHENIX crystallographic package [44].
The crystal structure of WT ma-DG-Nt (PDB ID: 1U2C
[18]) was used as a search template. Rigid body refinement
was initially carried out, followed by a simulated annealing
step. The following cycles of the crystallographic refinement
included positional refinement and translation-libration-
screw (TLS) model parameterization before the individual
B-factors refinement. All the refinement cycles were carried
out by using PHENIX.REFINE [45] and were alternated with
the manual rebuilding of the structure by using the COOT
software [46]. Solvent molecules were included in the final
model by using the automatic search protocol available in
PHENIX.REFINE and manually checked before being included
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in the model. Occupation of residues Asp160, His161,
Ser162, Ala184, and Asp185 that display a poor electron
density and a high Biso was also refined. Protein stereo-
chemistry was monitored throughout the refinement process
and during manual rebuilding with MolProbity [47]. Statis-
tics of the crystallographic refinement are reported in
Table 4. Coordinates and structure factors have been
deposited in the PDB, with accession number 5LLK.
Molecular diagrams were created with PYMOL [48] and the
STRIDE web server [49] has been used for ha-DG-Nt
secondary structure assignments. Protein structures super-
position and rmsd estimation were carried out by ProFit
(Martin, A.C.R., http://www.bioinf.org.uk/software/profit).
Small-angle X-ray scattering (SAXS)
Small-angle X-ray scattering data for ma-DG-Nt were col-
lected on the BM29 beamline [50] at the European Syn-
chrotron Radiation Facility (ESRF, Grenoble, France) as
10 9 1 s exposure time using a Pilatus 1M detector, sample
detector distance of 2.87 m and wavelength of 0.99 A.
SAXS measurements for ha-DG-Nt were taken on the P12
beamline EMBL SAXS-WAXS at PETRAIII/DESY (Ham-
burg, Germany) [51] as 20 9 0.05 s exposures time using a
Pilatus 2M detector, sample detector distance of 3.00 m
and wavelength of 1.24 A. Scattering profiles for the col-
lected frames were compared to detect radiation damage.
Measurements were taken at six different concentrations
(the ranges are reported in Table 3; additional details on
SAXS structural parameters are reported in Table S2) in
20 mM Tris, 150 mM NaCl, pH 7.5.
After normalization to the intensity of the transmitted
beam, frames were merged for each sample. Subtraction of
the buffer’s contribution to the scattering and further pro-
cessing steps were performed using PRIMUS [52] from the AT-
SAS 2.6.0 program package [28]. The forward scattering I(0)
and the Rg were evaluated using the Guinier approximation
[53], assuming that at very small angles (s < 1.3/Rg), the
intensity is represented as:
IðsÞ ¼ Ið0Þ  eðsRg Þ
2
3 :
Pair distance distribution functions of the particles p(r)
and the maximum sizes Dmax were computed using GNOM
[54]. MM was estimated by comparison of the calculated
forward scattering I(0) of the samples with that of the
standard solution of bovine serum albumin (MM 66 kDa).




The program DAMMIN [29] was employed to construct
low-resolution ab initio beads models of murine and
ha-DG-Nt that best fit the scattering data. It employs a
simulated annealing procedure to build a compact bead con-
figuration inside a sphere with the diameter Dmax that fits
the experimental data Iexp(s) to minimize the discrepancy:







Ten independent DAMMIN runs were performed for
each scattering profile in the ‘slow’ mode, using default
parameters and no symmetry assumptions (P1 symmetry).
The models resulting from independent runs were superim-
posed using the program SUPCOMB [30], and aligned
models were averaged using DAMAVER [56] to generate a
consensus three-dimensional shape.
A simulated annealing protocol implemented in CORAL
[28] was employed to find the optimal positions and





Unit cell parameters (A); a, c 71.8, 144.0
Molecules per asymmetric unit 1
Wavelength (A) 1.000
Resolution (A) 48.0–1.80 (1.85–1.80)a
Total observations 175 979 (12 160)






<I/r (I)> 21.60 (1.61)
Completeness (%) 99.0 (94.5)
Redundancy 7.0 (6.9)
Refinement
Resolution (A) 36–1.80 (1.864–1.80)a







Number of non-H atoms
Protein 1702
Waters 129
Organic (ethylene glycol) 8





Bond length (A) 0.01
Angle (deg) 1.01
Ramachandran plot
Favored regions (%) 99.0
Allowed regions (%) 1.0
Disallowed regions (%) 0.0
aValues in parentheses are given for the highest resolution shell.
bRmerge = ∑hkl∑j│Ihkl,j  <Ihkl>│/∑hkl∑j Ihkl,j.
cRmeas = ∑hkl [n/(n  1)]1/2∑j│Ihkl,j  <Ihkl>│/∑hkl∑j Ihkl,j
dRwork = ∑work set│Fobs  Fcal│/∑work set Fobs.
eR-free = ∑test set |Fobs  Fcal|/∑test set Fobs.
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orientations of the available high-resolution models of the
Ig-like and S6 domains of murine and human a-DG-Nt. In
addition, the program also generated approximate clash-
free conformations of the missing portions of polypeptide
chain (around 10 amino acids at both the N-terminal and
C-terminal regions and the missing linker between the Ig-
like and S6 domains). The model fit of the X-ray crystal
structures (PDB ID: 1U2C for ma-DG-NT and 5LLK for
ha-DG-Nt) against the SAXS data was calculated using
CRYSOL [27].
Analysis of the interdomain flexibility and size distribu-
tion of possible conformers, consistent with the measured
scattering data for murine and human a-DG-Nt, was con-
ducted using the EOM [31]. This method selects an ensem-
ble of possible conformations from a pool of 10 000
randomly generated models constructed from rigid domains
linked by randomly generated flexible linkers. The program
CRYSOL is used to calculate the theoretical scattering profiles
of these models, and a genetic algorithm, GAJOE, is used
to select an ensemble of conformations, whose combined
scattering profiles best fit the experimental data. The crystal
structures of the Ig-like and S6 domains of murine and
human a-DG-Nt were used as rigid bodies for the analysis
of the scattering data, employing ensemble optimization.
Linkers between the domains and missing N-terminal and
C-terminal stretches were represented as a flexible chain of
dummy residues.
Sequence alignment
Murine and human a-DG sequences were aligned in MUS-
CLE 3.8 [57] available at EMBL/EBI (http://www.ebi.ac.uk/
Tools/msa).
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